Skip to main content
      The emergence of large language models (LLMs) represents a promising shift in how complex diseases such as systemic lupus erythematosus (SLE) are communicated and interpreted across both patient and clinical settings. Two EULAR 2026 abstracts highlight the evolving role of LLMs across this spectrum, from patient-facing education to diagnostic reasoning.
      Much of the meeting came for the next CAR T readout. AB-101 drew attention for a different reason. It depletes B cells by a completely different route.
      PsA Topic Panel: EULAR 2026
      Across EULAR 2026 abstracts this year and presented in a session called “this is a woman’s world”, strong signals are emerging that the menopausal transition is associated with changes in disease phenotype, disease activity, and treatment response in both RA and PsA.
      Digital Platforms and AI

      Work was presented from three PARE initiatives that showcase how digital tools can be used in

      Dr. John Cush RheumNow

      4 days 7 hours ago
      Digital Platforms and AI Work was presented from three PARE initiatives that showcase how digital tools can be used in treatment education and decision-making, and potentially avoid the use of general web searches to answer important questions. https://t.co/LxXeFdAbU7 https://t.co/ocqSBhYHEf
      Understanding Comorbidities in RMD

      People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of

      Dr. John Cush RheumNow

      4 days 9 hours ago
      Understanding Comorbidities in RMD People with rheumatic and musculoskeletal diseases (RMD) are at risk of a number of comorbidities, from cardiovascular diseases to cognitive impairment and fractures. EIULAR 2026 showcased new data and ideas around various comorbidities and https://t.co/twr0EiMp9f
      All content is independently chosen and produced by the RheumNow faculty. RheumNow’s expanded coverage of the #EULAR20

      Dr. John Cush RheumNow

      4 days 11 hours ago
      All content is independently chosen and produced by the RheumNow faculty. RheumNow’s expanded coverage of the #EULAR2026 Annual Meeting is sponsored by Bristol Myers Squibb and UCB.
      Day 1 Report from EULAR 2026

      The first day of EULAR 2026 in London featured the opening ceremonies, a plenary session,

      Dr. John Cush RheumNow

      4 days 12 hours ago
      Day 1 Report from EULAR 2026 The first day of EULAR 2026 in London featured the opening ceremonies, a plenary session, posters nd the first round of major oral presentations to an audience of nearly 15,000 attendees. Here are a few of my favorites from the first day. https://t.co/qCnoiGedat
      #EULAR2026 Want to catch up with the latest breakthrough in research on the last day of the conference? Please find our

      Md Yuzaiful Md Yusof Yuz6Yusof

      4 days 14 hours ago
      #EULAR2026 Want to catch up with the latest breakthrough in research on the last day of the conference? Please find our Day 4 Daily Recap led by @RheumNow and joined by my colleagues @synovialjoints @DrMiniDey 😃 https://t.co/fONe6g4ne1 https://t.co/kOqzF8t64w
      RheumNow’s expanded coverage of the #EULAR2026 Annual Meeting is sponsored by Bristol Myers Squibb and UCB. RheumNow a

      Dr. John Cush RheumNow

      4 days 14 hours ago
      RheumNow’s expanded coverage of the #EULAR2026 Annual Meeting is sponsored by Bristol Myers Squibb and UCB. RheumNow and its faculty independently select all coverage content.
      Digital Patient Education in RA
      ×